2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986
Reimer P, Weissleder R, Wittenberg J, Brady TJ
Receptor-directed contrast agents for MR imaging: preclinical evaluation with affinity assays.
Radiology. 1992;182(2):565-9 - PMID: 1732982
Weissleder R, Lee AS, Khaw BA, Shen T, Brady TJ
Antimyosin-labeled monocrystalline iron oxide allows detection of myocardial infarct: MR antibody imaging.
Radiology. 1992;182(2):381-5 - PMID: 1732953
Reimer P, Weissleder R, Nickeleit V, Brady TJ
Animal models for magnetic resonance imaging research of the liver.
Invest Radiol. 1992;27(5):390-3 - PMID: 1582824
Reimer P, Kwong KK, Weisskoff R, Cohen MS, Brady TJ, Weissleder R
Dynamic signal intensity changes in liver with superparamagnetic MR contrast agents.
J Magn Reson Imaging. 1992;2(2):177-81 - PMID: 1562768
Josephson L, Groman E, Weissleder R
Contrast agents for magnetic resonance imaging of the liver.
Targeted Diagn Ther. 1992;4:163-87 - PMID: 1797156
Weissleder R, Bogdanov A, Papisov M
Drug targeting in magnetic resonance imaging.
Magn Reson Q. 1992;8(1):55-63 - PMID: 1567758
Weissleder R, Papisov M
Pharmaceutical iron oxides for MR imaging
JMRI. 1992;4:1:20
7